Hyaluronic acid injection similar in symptom & structure of knee OA vs diacerein & placebo .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis
Ann Rheum Dis. 2004 Dec;63(12):1611-7301 patients, over 50 years of age, with knee osteoarthritis, were randomized to receive either oral diacerein treatment (100mg/day) and 3 courses of intra-articular saline injections, oral placebo (100mg/day) and 3 courses of intra-articular saline injections, or oral placebo (100mg/day) and 3 courses of intra-articular hyaluronic acid injections (NRD101). The purpose of the study was to compare the 1-year symptomatic and structural efficacy and safety of hyaluronic acid injections compared to oral diacerein treatment and a placebo. The results indicated no significant differences in safety or symptomatic outcomes up to 1 year between groups, and no significant differences were noted in structural parameters either.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics